|
|
Volumn 107, Issue 5, 2012, Pages 792-
|
|
Clinical effects of statin use on gastric cancer prevention
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ATROPHIC GASTRITIS;
CANCER INCIDENCE;
CANCER PATIENT;
CANCER PREVENTION;
CANCER RISK;
COHORT ANALYSIS;
DRUG EFFECT;
FOLLOW UP;
HELICOBACTER INFECTION;
HUMAN;
LETTER;
NATIONAL HEALTH INSURANCE;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROBABILITY;
PROPENSITY SCORE;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK FACTOR;
RISK REDUCTION;
SAMPLE SIZE;
STOMACH CANCER;
TAIWAN;
NOTE;
RISK ASSESSMENT;
STOMACH TUMOR;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
RISK ASSESSMENT;
STOMACH NEOPLASMS;
|
|
EID: 84862304646
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2012.8 Document Type: Letter |
|
Times cited : (1)
|
|
References (3)
|
